How this fund's holdings score on the six lenses, weighted by holding weight — plus what the manager is actively buying and selling. A transparency roll-up of the stock atom — descriptive, not a forecast of outperformance.
What's a “leader”? A holding that ranks in the top two deciles (D9 / D10) of its size cohort on BOTH active conviction lenses — Technical and Flow. Leadership-breadth is the share of the fund's weight sitting in those leaders.
Risk & return
Compound returns and the risk taken to earn them, from the fund's own NAV history.
| Sector | 11 Jul | 18 Jul | 25 Jul | 24 Aug | 28 Aug | 04 Sep | Δ |
|---|---|---|---|---|---|---|---|
| Pharma | 53.4 | 53.4 | 53.4 | 57.5 | 57.5 | 57.5 | +4.1 |
| Healthcare | 32.7 | 32.7 | 32.7 | 33.3 | 33.3 | 33.3 | +0.6 |
| Chemicals | 9.1 | 9.1 | 9.1 | 7.5 | 7.5 | 7.5 | -1.6 |
| Unclassified | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | -0.0 |
Glass box
Click a lens to expand its holdings, ranked by contribution (weight × decile); each name links to its own evidence. Descriptive, not a forecast.
—
—
| Symbol | Sector | Weight | Tch | Fnd | Cat | Flw | Val | Lead | RS 3M |
|---|---|---|---|---|---|---|---|---|---|
| SUNPHARMA | Pharma | 12.72% | 7 | 8 | 7 | 8 | 5 | — | +1.5% |
| DIVISLAB | Pharma | 7.46% | 9 | 8 | 1 | 4 | 1 | — | +38.4% |
| ACUTAAS | Chemicals | 5.17% | 5 | 10 | 3 | 8 | 2 | — | -8.5% |
| CIPLA | Pharma | 5.07% | 4 | 3 | 6 | 4 | 7 | — | -3.9% |
| APOLLOHOSP | Healthcare | 4.98% | 9 | 5 | 5 | 2 | 2 | — | +0.4% |
| TORNTPHARM | Pharma | 4.74% | 7 | 8 | 5 | 4 | 1 | — | +7.0% |
| MAXHEALTH | Healthcare | 4.58% | 1 | 9 | 6 | 5 | 6 | — | -6.0% |
| LAURUSLABS | Pharma | 4.04% | 9 | 9 | 3 | 3 | 1 | — | +29.2% |
| AUROPHARMA | Pharma | 3.86% | 8 | 3 | 10 | 6 | 7 | — | +9.9% |
| ASTERDM | Healthcare | 3.65% | 6 | 2 | 9 | 4 | 2 | — | -0.6% |
| BIOCON | Pharma | 2.96% | 4 | 1 | 10 | 2 | 7 | — | -8.8% |
| JLHL | Healthcare | 2.88% | 1 | 9 | 4 | 2 | 10 | — | -83.0% |
| ANTHEM | Pharma | 2.82% | 10 | 10 | 6 | 3 | 1 | Leader | +16.3% |
| GLAND | Pharma | 2.78% | 10 | 7 | 5 | 4 | 4 | Leader | +27.9% |
| FORTIS | Healthcare | 2.63% | 4 | 8 | 5 | 5 | 6 | — | -12.4% |
| SAILIFE | Healthcare | 2.44% | 9 | 10 | 5 | 9 | 1 | Leader | +27.8% |
| AETHER | Chemicals | 2.28% | 7 | 9 | 4 | 3 | 1 | — | +38.1% |
| SUDEEPPHRM | Pharma | 2.22% | 6 | 9 | 2 | 2 | 1 | — | +76.9% |
| POLYMED | Healthcare | 2.02% | 6 | 6 | 5 | 6 | 6 | — | +18.6% |
| KIMS | Healthcare | 1.98% | 4 | 3 | 6 | 10 | 2 | — | -9.0% |
| AJANTPHARM | Pharma | 1.93% | 8 | 10 | 1 | 3 | 3 | — | +13.9% |
| CONCORDBIO | Pharma | 1.89% | 8 | 4 | 2 | 5 | 3 | — | +16.2% |
| MANKIND | Pharma | 1.83% | 4 | 8 | 9 | 3 | 5 | — | -6.1% |
| LUPIN | Pharma | 1.79% | 3 | 10 | 10 | 7 | 9 | — | -11.1% |
| COHANCE | Healthcare | 1.73% | 4 | 5 | 6 | 3 | 5 | — | +1.5% |
| MEDANTA | Healthcare | 1.67% | 8 | 9 | 5 | 4 | 2 | — | +13.1% |
| NEPHROPLUS | Healthcare | 1.20% | 6 | 5 | 6 | 5 | 9 | — | +2.5% |
| LALPATHLAB | Healthcare | 1.06% | 7 | 8 | 7 | 5 | 3 | — | +18.6% |
| ABBOTINDIA | Pharma | 1.03% | 3 | 9 | — | 6 | 8 | — | -3.8% |
| SYNGENE | Healthcare | 0.96% | 1 | 2 | 6 | 7 | 7 | — | -17.8% |
| RAINBOW | Healthcare | 0.85% | 10 | 7 | 4 | 3 | 4 | — | +5.0% |
| HCG | Healthcare | 0.73% | 7 | 2 | 6 | 7 | 2 | — | +5.1% |
| GUFICBIO | Pharma | 0.36% | 9 | 4 | 3 | 6 | 1 | Leader | +14.5% |
Performance · 5.0y
Over the last 5.0 years ₹100 in the fund grew to ₹224 (+124%), vs ₹156 for Nifty 500 (+56%) and ₹137 for Nifty 50 (+37%). Its relative-strength line ended at 164 vs Nifty 50 and 144 vs Nifty 500 — above 100, sustained outperformance.